The crystal structure of guinea pig 11beta-hydroxysteroid dehydrogenase type 1 provides a model for enzyme-lipid bilayer interactions.
The metabolic reduction of 11-keto groups in glucocorticoid steroids such as cortisone leads to the nuclear receptor ligand cortisol. This conversion is an example of pre-receptor regulation and constitutes a novel pharmacological target for the treatment of metabolic disorders such as insulin resis...
Asıl Yazarlar: | Ogg, D, Elleby, B, Norström, C, Stefansson, K, Abrahmsén, L, Oppermann, U, Svensson, S |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2005
|
Benzer Materyaller
-
Comparative enzymology of 11 beta -hydroxysteroid dehydrogenase type 1 from glucocorticoid resistant (Guinea pig) versus sensitive (human) species.
Yazar:: Shafqat, N, ve diğerleri
Baskı/Yayın Bilgisi: (2003) -
High-level production and optimization of monodispersity of 11beta-hydroxysteroid dehydrogenase type 1.
Yazar:: Elleby, B, ve diğerleri
Baskı/Yayın Bilgisi: (2004) -
Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism.
Yazar:: Hult, M, ve diğerleri
Baskı/Yayın Bilgisi: (2004) -
Glucocorticoid activation by 11beta-hydroxysteroid dehydrogenase type 1: A novel pharmacological target in the metabolic syndrome
Yazar:: Oppermann, U, ve diğerleri
Baskı/Yayın Bilgisi: (2003) -
Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
Yazar:: Hult, M, ve diğerleri
Baskı/Yayın Bilgisi: (2006)